Characteristic | All patients (n = 48) |
---|---|
Age (years) | 66 ± 11 |
Gender (male/female) | 32/16 |
WBC (/μL) | 6747 ± 2794 |
TLC (/μL) | 1627 ± 601 |
Alb (mg/dL) | 3.8 ± 0.5 |
CRP (mg/dL) | 0.65 ± 1.83 |
Tumor characteristic | |
 Differentiation (tub1/tub2/other) | 27/19/2 |
 CEA (</≥ 5 ng/mL) | 34/14 |
 CA19-9 (</≥ 37 IU/mL) | 40/8 |
 Pre-CRT stage (I/II/II) | 3/11/28 |
Treatment | |
 Chemotherapy (S-1/UFT/5-FU) | 29/8/11 |
 Surgery (LAR/ISR/APR/local) | 18/11/17/2 |